Nerve Transfer Surgery for Stroke Recovery
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that contralateral C7 nerve transfer has successfully restored hand function in patients with spastic hemiplegia (paralysis on one side of the body) from chronic central nervous system injuries, suggesting its potential effectiveness for stroke recovery.
12345The contralateral C7 nerve transfer has been used in treating conditions like brachial plexus injuries in children, suggesting it is generally safe, but specific safety data for stroke recovery is not detailed in the available studies.
12367Contralateral C7 nerve transfer is unique because it involves transferring a nerve from the healthy side of the body to the affected side, which can help restore function in patients with spastic paralysis from stroke. This surgical approach is different from other treatments as it directly targets nerve pathways to improve movement, rather than relying on medication or physical therapy alone.
12358Eligibility Criteria
This trial is for stroke survivors with arm weakness or paralysis who haven't seen improvement after 1-5 years of rehab. It's not suitable for pregnant individuals.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo contralateral C7 root transfer surgery for the treatment of spastic hemiparesis
Follow-up
Participants are monitored for changes in arm function using the Fugl-Meyer upper-extremity scale
Participant Groups
Contralateral C7 root transfer is already approved in China, United States, European Union for the following indications:
- Upper limb paralysis due to stroke
- Brachial plexus injury
- Upper limb paralysis due to stroke
- Traumatic brachial plexus injury
- Upper limb paralysis due to stroke
- Brachial plexus avulsion injury